Journal article
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.
- Abstract:
-
Nicotine is the principal addictive component in tobacco, and following uptake acts in the central nervous system. The smoking-cessation efforts of most smokers fail because a single slip often delivers sufficient nicotine to the brain to reinstate the drug-seeking behaviour. Blocking nicotine from entering the brain by induction of specific antibodies may be an effective means to prevent such relapses. The hapten nicotine was coupled to virus-like particles (VLP) formed by the coat protein o...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- European journal of immunology
- Volume:
- 35
- Issue:
- 7
- Pages:
- 2031-2040
- Publication date:
- 2005-07-01
- DOI:
- EISSN:
-
1521-4141
- ISSN:
-
0014-2980
- Source identifiers:
-
469731
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:469731
- UUID:
-
uuid:13d76d51-c62f-4cd2-bba0-597326c395db
- Local pid:
- pubs:469731
- Deposit date:
- 2014-06-18
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record